Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00841971 · ClinicalTrials.gov registry record · Phase 4
Anidulafungin Versus Fluconazole for the Prevention of Fungal Infections in Liver Transplant Recipients
A Phase 4 study of Mycoses and Fungemia, sponsored by University of Pittsburgh.
- Completed
- Registry status
- Phase 4
- Development phase
- 200
- Enrollment target
- 6
- Study locations
NCT00841971: Completed Phase 4 study of Mycoses and Fungemia, sponsored by University of Pittsburgh.
NCT00841971 is a Phase 4 study of Mycoses and Fungemia that has completed, run by University of Pittsburgh. The registered enrollment target is 200 participants, below the 318-participant average among 7 other Mycoses trials with a reported enrollment target (37% lower). The trial reports 6 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00841971, a Phase 4 study of Mycoses and Fungemia, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 200 participants
- Enrollment target
- 6
- Study locations
Study Summary
The purpose of this study is to compare the efficacy of anidulafungin versus fluconazole for the prevention of fungal diseases in liver transplant recipients
Conditions Studied
Interventions
- DRUG Fluconazole
- DRUG Anidulafungin
Study Locations (6)
California
- UCLA Medical Cente - Los Angeles
Florida
- University of Miami - Miami
Michigan
- University of Michigan - Ann Arbor
Pennsylvania
- University of Pittsburgh - Pittsburgh
Washington
- University of Washington Medical Center - Seattle
Wisconsin
- University of Wisconsin - Madison - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2010-02 |
| Est. Completion | 2014-05 |
| Phase | Phase 4 |
What the finished NCT00841971 record still lists
NCT00841971 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 318-participant average among 7 other Mycoses trials with a reported enrollment target (37% lower).
The record links to 4 conditions, with Mycoses appearing as the primary indexed condition, and to 2 interventions - of which Fluconazole is the first listed.
NCT00841971 lists 6 locations in 6 states (California, Florida, Michigan).
Frequently Asked Questions
What is clinical trial NCT00841971 about?
NCT00841971 is a clinical study titled "Anidulafungin Versus Fluconazole for the Prevention of Fungal Infections in Liver Transplant Recipients". The purpose of this study is to compare the efficacy of anidulafungin versus fluconazole for the prevention of fungal diseases in liver transplant recipients
What is the current status of trial NCT00841971?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 200 participants. The study started on 2010-02. Estimated completion is 2014-05.
What conditions does trial NCT00841971 study?
This clinical trial studies the following conditions: Mycoses, Fungemia, Central Nervous System Fungal Infections, Lung Diseases, Fungal.
What interventions are being tested in trial NCT00841971?
The interventions under investigation include: Fluconazole (DRUG), Anidulafungin (DRUG).
Who is sponsoring clinical trial NCT00841971?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00841971 being conducted?
This trial has 6 study locations across California, Florida, Michigan, Pennsylvania, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Mycoses
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Prospective Data Bank Creation to Study Vaginal Conditions
RECRUITING
-
Study of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow Transplantation
ACTIVE NOT RECRUITING · Phase 3
-
Isavuconazole (BAL8557) in the Treatment of Candidemia and Other Invasive Candida Infections
COMPLETED · Phase 3
-
An Open Label, Non-Comparative, Multicenter, Phase III Trial of the Efficacy, Safety and Toleration of Voriconazole in the Primary or Secondary Treatment of Invasive Fungal Infections
COMPLETED · Phase 3
-
CD101 Compared to Caspofungin Followed by Oral Step Down in Subjects With Candidemia and/or Invasive Candidiasis-Bridging Extension
COMPLETED · Phase 2
-
An Open Label, Non-Comparative, Multicenter, Phase III Trial of the Efficacy, Safety and Toleration of Voriconazole in the Primary or Secondary Treatment of Invasive Fungal Infections
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia